M Pharmaceutical to Reprice 1.43 Million Warrants

M Pharmaceutical Inc. (CSE:MQ) announced today that it has resolved to reprice 1.1 million warrants previously due to expire on Sept. 13, 2015, and 330,000 warrants due to expire on Feb. 25, 2016.
As quoted in the press release:

The exercise price of each of September, 2015, warrants and the February, 2016, warrants has been changed to 13 cents. Further, it was resolved to extend the expiry date of the September, 2015, warrants until the close of business (Vancouver, B.C., local time) on Oct. 31, 2015. The expiry date of the February, 2016, warrants has not been amended and will expire on Feb. 25, 2016. No further amendments have been made to either the September, 2015, warrants or the February, 2016, warrants; all other terms and conditions, as detailed in the respective warrant certificates, remain in effect.
The company will notify affected registered warrantholders by mail or by e-mail. Original, paper warrant certificates will not be replaced. In order to exercise the September, 2015, warrants or the February, 2016, warrants, holders shall provide the original warrant certificates to the company with a cheque in the amount of 13 cents per exercised warrant prior to the applicable expiry date.

M Pharmaceutical CEO, Matthew Lehman, stated:

I am pleased that the company is able to amend the terms of existing warrants. I believe this will provide the company capital to progress our development plans for Trimeo, Trimtec and eMosquito.

Connect with M Pharmaceutical Inc. (CSE:MQ) to receive an Investor Kit